NasdaqCM - Nasdaq Real Time Price USD

Jin Medical International Ltd. (ZJYL)

Compare
0.7780 +0.0181 (+2.38%)
At close: December 13 at 4:00:01 PM EST
0.8000 +0.02 (+2.83%)
After hours: December 13 at 6:35:22 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
19,821.4570
19,821.4570
19,190.5410
20,764.2730
16,193.7630
Cost of Revenue
13,036.6230
13,036.6230
12,992.0230
14,403.1370
10,695.5530
Gross Profit
6,784.8340
6,784.8340
6,198.5180
6,361.1360
5,498.2100
Operating Expense
3,917.5720
3,917.5720
4,067.9940
3,729.6340
3,143.5370
Operating Income
2,867.2620
2,867.2620
2,130.5240
2,631.5020
2,354.6730
Net Non Operating Interest Income Expense
182.6820
182.6820
181.6050
-9.4920
-112.4040
Other Income Expense
171.9930
171.9930
430.5090
258.3370
110.8830
Pretax Income
3,221.9370
3,221.9370
2,742.6380
2,880.3470
2,353.1520
Tax Provision
343.7070
343.7070
36.1110
248.6410
147.1540
Net Income Common Stockholders
2,878.2300
2,878.2300
2,706.5270
2,631.7060
2,205.9980
Diluted NI Available to Com Stockholders
2,878.2300
2,878.2300
2,706.5270
2,631.7060
2,205.9980
Basic EPS
0.02
--
0.02
0.02
0.01
Diluted EPS
0.02
--
0.02
0.02
0.01
Basic Average Shares
145,136.9800
--
150,000.0000
155,000.0000
160,000.0000
Diluted Average Shares
145,136.9800
--
150,000.0000
155,000.0000
160,000.0000
Total Operating Income as Reported
2,867.2620
2,867.2620
2,130.5240
2,631.5020
2,354.6730
Total Expenses
16,954.1950
16,954.1950
17,060.0170
18,132.7710
13,839.0900
Net Income from Continuing & Discontinued Operation
2,878.2300
2,878.2300
2,706.5270
2,631.7060
2,205.9980
Normalized Income
2,923.2426
2,923.2426
2,522.5561
2,573.7995
2,217.6151
Interest Income
--
--
181.6050
--
--
Interest Expense
--
--
--
9.4920
112.4040
Net Interest Income
182.6820
182.6820
181.6050
-9.4920
-112.4040
EBIT
2,867.2620
2,867.2620
2,130.5240
2,631.5020
2,465.5560
EBITDA
3,093.1640
3,093.1640
2,493.1210
2,978.1100
2,795.4630
Reconciled Cost of Revenue
13,036.6230
13,036.6230
12,992.0230
14,403.1370
10,695.5530
Reconciled Depreciation
225.9020
225.9020
362.5970
346.6080
329.9070
Net Income from Continuing Operation Net Minority Interest
2,878.2300
2,878.2300
2,706.5270
2,631.7060
2,205.9980
Total Unusual Items Excluding Goodwill
-50.4060
-50.4060
186.3940
63.3550
-12.3920
Total Unusual Items
-50.4060
-50.4060
186.3940
63.3550
-12.3920
Normalized EBITDA
3,143.5700
3,143.5700
2,306.7270
2,914.7550
2,807.8550
Tax Rate for Calcs
0.0001
0.0001
0.0000
0.0001
0.0001
Tax Effect of Unusual Items
-5.3934
-5.3934
2.4231
5.4485
-0.7749
9/30/2020 - 3/28/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MLSS Milestone Scientific Inc.
0.8100
-2.41%
 
MHUA Meihua International Medical Technologies Co., Ltd.
0.5009
-13.20%
 
S2M.ST S2Medical AB (publ)
0.0095
0.00%
 
LUCY Innovative Eyewear, Inc.
6.11
+3.56%
 
FEMY Femasys Inc.
1.1900
0.00%
 
IZAFE-B.ST iZafe Group AB (publ)
0.2100
-5.41%
 
MBOT Microbot Medical Inc.
1.0000
+0.07%
 
AVGR Avinger, Inc.
0.6309
+2.37%
 
NEPH Nephros, Inc.
1.5500
0.00%
 
STSS Sharps Technology, Inc.
2.0400
+2.51%